Glienicke-Nordbahn, Germany

Stefan Bracht

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Glienicke Nordbahn, DE (2013 - 2015)
  • Jena, DE (2014 - 2015)
  • Berlin, DE (2016)

Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Unveiling the Innovations of Inventor Stefan Bracht

Introduction

Stefan Bracht, an accomplished inventor based in Glienicke-Nordbahn, Germany, has made significant contributions to pharmaceutical technology. With a total of five patents to his name, Bracht specializes in transdermal therapeutic systems, a field that bridges the gap between pharmacology and practical medical applications. His innovative approaches have the potential to enhance drug delivery methods, particularly for hormonal therapies.

Latest Patents

Among his latest patents, one notable invention is the "Transdermal therapeutic system with crystallization-inhibiting protective film (release liner)." This innovation addresses the challenges associated with active ingredients crystallizing at the interface of the protective film and the drug matrix, thereby improving the efficacy of transdermal patches.

Another significant patent is focused on "Transdermal delivery of hormones with low concentration of penetration enhancers." This invention introduces a patch that delivers hormones such as gestodene and optional estrogen at effective plasma levels without the need for penetration enhancers. The design allows for weekly administration, offering a practical solution for female contraception.

Career Highlights

Stefan Bracht has collaborated with prominent companies in the pharmaceutical sector, notably Bayer Intellectual Property GmbH and LTS Lohmann Therapie-systeme AG. His work in these organizations has contributed to advancing drug delivery technologies, ensuring that patients have access to effective treatments.

Collaborations

Bracht has had the opportunity to work alongside acclaimed professionals in the field, including Thomas Langguth and Michael Dittgen. These collaborations have played a crucial role in developing Bracht's innovative ideas into tangible patents and products that cater to medical needs.

Conclusion

Stefan Bracht's innovations in transdermal therapeutic systems are a testament to his commitment to improving healthcare solutions. Through his patents, he has paved the way for advancements in hormonal delivery methods, demonstrating the impact that dedicated inventors can have in the pharmaceutical industry. His career reflects a blend of creativity, collaboration, and a passion for enhancing patient care through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…